In re: Emoral, Inc.

Aaroma acquired certain assets and liabilities of Emoral, a manufacturer of diacetyl, a chemical used in the food flavoring industry. The parties were aware of potential claims arising from exposure to diacetyl. Their agreement stated that Aaroma was not assuming liabilities related to “Diacetyl Litigation,” and was not purchasing Emoral’s corresponding insurance coverage. Emoral filed for bankruptcy. The Trustee and Aaroma entered into an agreement, under which Aaroma paid $500,000 and the Trustee released Aaroma from any “causes of action . . . that are property of the Debtor’s Estate.” In response to objections by the Diacetyl Claimants, the parties added that their agreements would not “operate as a release of, or a bar to prosecution of any claims held by any person which do not constitute Estate’s Released Claims.” The Bankruptcy Court approved the settlement without resolving whether the Diacetyl claims constituted “Estate’s Released Claims.” The Diacetyl Claimants filed individual complaints, alleging that Aaroma was a “mere continuation” of Emoral. The Bankruptcy Court held that the Diacetyl claims were not property of the estate. The district court reversed, finding that the claim for successor liability was a “generalized” claim belonging to the estate because a finding that Aaroma was a “mere continuation” of Emoral would benefit Emoral’s creditors generally. The Third Circuit affirmed. Because the Diacetyl claim belongs to the bankruptcy estate, it falls within the “Estate’s Released Claims.” The Diacetyl Plaintiffs have no apparent recourse against Aaroma. View "In re: Emoral, Inc." on Justia Law